IP Library Granted Patent US 11,330,998
Granted Patent B2
US 11,330,998 · App. 16/712,029 · Granted May 17, 2022

Skin sodium measurement using bioimpedance

Inventors: Fansan Zhu (Flushing, NY); Peter Kotanko (New York, NY)
Assignee: Fresenius Medical Care Holdings, Inc.
A61B5/0537A61B5/055A61B5/0531A61B5/1477A61B5/14546A61B5/443A61B5/7225A61B5/7246A61B5/7275A61B5/7278A61B5/0004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,330,998
App. No.
16/712,029
Granted
May 17, 2022
Kind
B2
Abstract

A technique for determining skin sodium content using bioimpedance spectroscopy includes applying a current at a predetermined frequency to skin of a subject, measuring a voltage across the skin of the subject produced by the current, determining a resistance across the skin of the subject at the predetermined frequency using the measured voltage, and determining skin sodium content using the measured voltage.

Claims (26)

1. A method for determining skin sodium content using bioimpedance spectroscopy, the method comprising:

applying a current at a predetermined frequency to skin of a subject;

measuring a voltage across the skin of the subject produced by the current;

determining a resistance across the skin of the subject at the predetermined frequency using the measured voltage; and

determining, using the measured voltage, skin sodium content using a regression model including a formula, SSC=a*ρ SR +b*age+c, where ρ SR is calculated skin resistivity, and wherein a, b, and c are constant coefficients configured to correlate skin sodium content obtained by sodium-magnetic resonance imaging with skin resistivity obtained by bioimpedance spectroscopy.

2. The method of claim 1 , further comprising calculating skin resistivity at the predetermined frequency, wherein the skin sodium content is determined at least in part using the calculated skin resistivity.

3. The method of claim 2 , wherein the skin resistivity (ρ SR ) is calculated using a formula, ρ SR =R F *A/L, where R F is the resistance at the predetermined frequency, A is a cross-sectional area of a measurement region of the skin, and L is a distance between electrodes that measured the voltage.

4. The method of claim 1 , wherein the predetermined frequency is in a range between 1 Hertz (Hz) and 1 megahertz (MHz).

5. The method of claim 1 , wherein the current is applied to dermis of the subject.

6. The method of claim 1 , wherein the predetermined frequency is selected to traverse through dermis of the subject.

7. The method of claim 1 , further comprising:

altering the predetermined frequency;

repeating measurement of the voltage and determining the resistance at the altered frequency to determine a tissue type of the subject; and

selecting the altered frequency determined to provide skin resistivity for dermis of the subject.

8. The method of claim 1 , further comprising:

determining one or more of a conductivity and a dielectric constant for current applied at a plurality of different frequencies;

determining a slope for one or more of the conductivity and the dielectric constant between at least two of the plurality of different frequencies; and

determining a tissue type using the slope.

9. The method of claim 8 , wherein the tissue type includes one of skin, fat, and muscle, and wherein tissue types of fat and muscle are disregarded for calculating skin sodium content.

10. The method of claim 8 , wherein the tissue type includes one of epidermis, dermis, and subcutaneous layer, and wherein all tissue types except the dermis are disregarded for calculating skin sodium content.

11. The method of claim 1 , further comprising associating the skin sodium content with a physiological characteristic to determine a predictive health condition of the subject.

12. The method of claim 1 , further comprising transmitting data to a computing device, the data including one or more of the predetermined frequency, the voltage, the resistance, skin resistivity, and the skin sodium content.

13. The method of claim 1 , further comprising measuring extracellular volume (ECV) and intracellular volume (ICV) of the skin.

14. The method of claim 1 , further comprising:

continuously calculating skin sodium content for a predetermined time period; and

transmitting a notification when skin sodium content is outside of a predetermined range.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2019
From: ZHU, FANSAN; KOTANKO, PETER
To: FRESENIUS MEDICAL CARE HOLDINGS, INC.
Reel/Frame 051341/0654 →
Continuity (2)
Provisional Application 62783581 · Dec 21, 2018
Related Publication 20200196903A1 · Jun 25, 2020